Thomas Lynch Jr., Bristol-Myers Squibb's R&D chief, is set to leave in October, and his job will be split in two
Tablets on the production line of a Bristol-Myers Squibb facility in France. Photo: georges gobet/Agence France-Presse/Getty Images By Jared S. Hopkins June 5, 2019 6:59 a.m. ET Bristol-Myers Squibb Co.’s BMY 1.11% research-and-development chief will leave the company later this year after the drugmaker completes its $74 billion acquisition of rival Celgene Corp. CELG 0.77% and will hand over his responsibilities to a pair of scientists from outside the company.
The later stages of developing drugs, before they go up for approval and come to market, will be handled by Samit Hirawat, the incoming chief medical officer. He comes from Novartis AG NVS -0.27% , where he led cancer development. Dr. Lynch had spent more than two decades at Massachusetts General Hospital and is a former director of the Yale Cancer Center. He took charge of Bristol R&D after serving on its board while the company was trying to recover from the failure of a key study for flagship immunotherapy Opdivo.
The new structure assigns one official to oversee the earliest science and another to manage the latter stages of development and regulatory submissions. Bristol has emphasized the incoming pipeline from Celgene since the deal was announced in January. The drugmaker is getting several drugs in the late-stages of development that could be up for approval and launch in the near term.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
San Francisco city hires adviser to explore potential acquisition of PG&E assetsSan Francisco Public Utilities Commission said on Tuesday it has hired an advise...
Weiterlesen »
Mark Zuckerberg's personal security chief accused of sexual misconduct, racist and homophobic commentsMark Zuckerberg’s personal security chief has been accused of sexual misconduct and making racist and homophobic remarks about Zuckerberg’s wife, Priscilla Chan, and members of his staff, a spokesperson for Zuckerberg says.
Weiterlesen »
Acting Pentagon chief says no need to restore suspended U.S.-South Korea military drillsActing U.S. Defense Secretary Patrick Shanahan said on Sunday that for now it wa...
Weiterlesen »
The next recession, Mark Zuckerberg's security chief, and UnitedHealth Group's $100 billion goalIt was a rough week for markets, with Donald Trump's decree that the US will impose tariffs of 5% on Mexican imports sending stocks into a spin.
Weiterlesen »
Trump is 'absolutely deadly serious' about Mexico tariffs, says acting White House chief of staff'I fully expect these tariffs to go onto the at least 5 percent level on June 10th,' Mick Mulvaney said.
Weiterlesen »
Officers engaged Virginia Beach gunman 8 minutes after 911 call came in: ChiefVirginia Beach officials have released a timeline of events in the shooting at the city's municipal building that killed 12 people and injured several more on Friday afternoon.
Weiterlesen »
Trump announces departure of chief economist HassettKevin Hassett, chairman of the White House Council of Economic Advisers, will leave the Trump administration, President Donald Trump announced Sunday
Weiterlesen »
Nancy Pelosi's refusal to impeach Donald Trump is 'insane' and 'pathetic,' Bush ethics chief'Are they trying to lose?' ex-White House ethics chief Richard Painter said of Democrats and the 2020 election.
Weiterlesen »
The end of the iTunes era: The life and death of Apple's curator-in-chiefAcross decades in music, Gary Stewart became an influential curator, admired taste-maker and beloved friend to many. That wasn't enough to save his life.
Weiterlesen »
Acting Defense Chief Will Skip a Formal Probe Into USS McCainActing Defense Secretary Pat Shanahan said he doesn’t plan to initiate an independent review by Pentagon investigators into a White House request that the USS John S. McCain be kept “out of sight” during President Trump’s visit to Japan last month.
Weiterlesen »